Related Experiment Videos
Recurrent coliform mastitis in the dairy cow
The Veterinary Record
|September 29, 1979
Summary
Experimental E. coli mastitis can lead to recurring infections in dairy cows. Bacteria may persist within mammary gland tissue, requiring specific antibiotic treatments for effective resolution.
Area of Science:
- Veterinary Medicine
- Microbiology
- Animal Science
Background:
- Bovine mastitis is a significant concern in dairy farming, impacting animal health and milk production.
- Escherichia coli (E. coli) is a common causative agent of mastitis, often leading to acute inflammation.
- Understanding the persistence and recurrence patterns of E. coli infections is crucial for effective management.
Purpose of the Study:
- To investigate the long-term course and characteristics of experimental E. coli mastitis in dairy cows.
- To determine the localization of bacteria during remission periods.
- To evaluate the efficacy of antibiotic therapy in resolving persistent E. coli mastitis.
Main Methods:
- Daily monitoring of milk for bacterial counts and neutrophil levels over 120 days.
- Experimental induction of E. coli mastitis in a cohort of dairy cows.
- Isolation and serotyping of bacteria during acute and remission phases.
- In vitro antibiotic susceptibility testing and in vivo therapeutic trials.
Main Results:
- Five out of 28 experimentally infected cows developed long-continued and recurring mastitis.
- Recurring episodes involved acute inflammation and pyrexia, with consistent serotypes of E. coli isolated.
- Periods of remission without detectable bacteria in milk suggested intracellular bacterial localization within mammary tissue.
- One antibiotic effective in vitro failed to resolve the infection in vivo, while another proved successful.
Conclusions:
- E. coli can establish persistent, recurring infections within bovine mammary gland tissue, not just the cistern.
- Intracellular bacterial persistence complicates treatment and necessitates targeted therapeutic strategies.
- Effective antibiotic selection is critical, as in vitro efficacy does not always predict in vivo success for mastitis treatment.